Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02186379 · ClinicalTrials.gov registry record · NA
Eating RePace Study
A NA study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT02186379 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 28 participants.
The verdict
NCT02186379, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The aims of this study are to develop a novel family-based behavioral intervention (Re-Pace) to help children at risk for obesity (children who eat rapidly and have an overweight parent/legal guardian) develop a more normal eating rate.
Interventions
- BEHAVIORAL Usual Care Control
- BEHAVIORAL RePace Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2012-11 |
| Est. Completion | 2014-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02186379
The ClinicalTrials.gov registry entry for NCT02186379 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care Control is the first listed.
NCT02186379 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02186379 about?
NCT02186379 is a clinical study titled "Eating RePace Study". The aims of this study are to develop a novel family-based behavioral intervention (Re-Pace) to help children at risk for obesity (children who eat rapidly and have an overweight parent/legal guardian) develop a more normal eating rate.
What is the current status of trial NCT02186379?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2012-11. Estimated completion is 2014-10.
What interventions are being tested in trial NCT02186379?
The interventions under investigation include: Usual Care Control (BEHAVIORAL), RePace Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02186379?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.